Hosted by Drug Discovery World and sponsored by Benchling, this free webinar explores the impact of AI on drug discovery innovation.

The webinar sees AI experts and leaders discuss where innovation is occurring and what the challenges are to overcome in drug discovery and development.

You will hear from Martin Brenner, CEO and CSO of iBio; Raminderpal Singh, Global Head of AI & GenAI Practice, 20/15 Visioneers; Sid Jain, SVP of Clinical Development & Data Science at Recursion; as well as a sponsor presentation from Sandy Li, Head of Scientific AI/ML Market Strategy at Benchling and Jannick Bendtsen, Head of PipeBio at Benchling.

You will learn how:

• AI is transforming drug discovery and development
• To navigate the limitations and challenges of implementing AI in R&D
• AI is already being used effectively in real-world drug development research
• Small to mid-size biotechs can also adopt and benefit from AI-driven approaches

A Q&A with the speakers follows the presentations.